These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7890060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
    Koopersmith TB, Lobo RA.
    Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR, Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [Abstract] [Full Text] [Related]

  • 8. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K, Viegas OA, Loke DF, Ratnam SS.
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [Abstract] [Full Text] [Related]

  • 9. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 10. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
    Toppozada MK, Ramadan M, el-Sawi M, Mehanna MT, Khamis Y, Marzouk S.
    Contraception; 1997 Jan; 55(1):7-10. PubMed ID: 9013054
    [Abstract] [Full Text] [Related]

  • 11. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY, Yang YS, Tseng LH, Ko TM, Hsu MC, Chuang SM.
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [Abstract] [Full Text] [Related]

  • 12. NORPLANT contraceptive implants advancing.
    Segal SJ.
    Netw Res Triangle Park N C; 1984 May; 5(3):1-3. PubMed ID: 12279797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Let's talk about Norplant: advances in steroidal contraception].
    Martinez JE.
    Profamilia; 1992 Dec; 8(20):28-34. PubMed ID: 12286384
    [Abstract] [Full Text] [Related]

  • 16. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
    Affandi B, Cekan SZ, Boonkasemsanti W, Samil RS, Diczfalusy E.
    Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
    [Abstract] [Full Text] [Related]

  • 17. Use of Norplant in women with or at-risk for noninsulin-dependent diabetes.
    Womack J, Beal MW.
    J Nurse Midwifery; 1996 Feb; 41(4):285-96. PubMed ID: 8828314
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of insulin sensitivity and glucose metabolism in women using a continuous subdermal levonorgestrel implant system.
    Harper MA, Meis PJ, Steele L.
    J Soc Gynecol Investig; 1997 Feb; 4(2):86-9. PubMed ID: 9101467
    [Abstract] [Full Text] [Related]

  • 19. Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.
    Kahn HS, Curtis KM, Marchbanks PA.
    Diabetes Care; 2003 Jan; 26(1):216-25. PubMed ID: 12502684
    [Abstract] [Full Text] [Related]

  • 20. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE.
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.